JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Journal of Antimicrobial Chemotherapy, published monthly by Oxford University Press in the United Kingdom (ISSN 0305-7453), is a premier peer-reviewed journal dedicated to the comprehensive study of antimicrobial chemotherapy. As a highly cited publication indexed in the Science Citation Index (SCI) and consistently ranked in the top tier of the Chinese Academy of Sciences journal classifications for medicine and pharmacy, the journal serves as a critical platform for disseminating high-impact research at the intersection of basic microbiology and clinical application. Its scope encompasses the discovery and development of new antimicrobial agents, the elucidation of resistance mechanisms, and the optimization of clinical treatment strategies, reflecting a rigorous commitment to scientific excellence and clinical relevance. While the journal operates on a hybrid model that allows for optional open access, it maintains strict editorial standards that result in a highly competitive submission process and a significant rejection rate. Consequently, it stands as an authoritative venue for researchers and clinicians seeking to publish innovative, high-quality studies that advance the understanding and management of infectious diseases and antimicrobial resistance globally.